{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:17:24Z","timestamp":1785367044528,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.drugalcdep.2011.10.016","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T17:12:35Z","timestamp":1321549955000},"page":"72-78","source":"Crossref","is-referenced-by-count":78,"title":["The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone"],"prefix":"10.1016","volume":"123","author":[{"given":"Bradley D.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sorbero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0175","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1176\/appi.ps.53.12.1547","article-title":"Mental health care for Latinos: Inequalities in use of specialty mental health services among Latinos, African Americans, and non-Latino Whites","volume":"53","author":"Alegria","year":"2002","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0005","series-title":"Methadone Maintenance Program and Patient Census in the US","author":"American Methadone Treatment Association","year":"1998"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsat.2010.05.004","article-title":"Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians","volume":"39","author":"Arfken","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0015","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1360-0443.2009.02539.x","article-title":"Comparison of costs and utilization among buprenorphine and methadone patients","volume":"104","author":"Barnett","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsat.2011.02.002","article-title":"Factors associated with Medicaid patients\u2019 access to buprenorphine treatment","volume":"41","author":"Baxter","year":"2011","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2007.11.018","article-title":"Opioid use disorder in the United States: insurance status and treatment access","volume":"94","author":"Becker","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0030","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/pds.1452","article-title":"Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States","volume":"16","author":"Cicero","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0035","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1377\/hlthaff.2010.0532","article-title":"The evidence doesn\u2018t justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine","volume":"30","author":"Clark","year":"2011","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.MLR.0000053228.58042.E4","article-title":"The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients","volume":"41","author":"Cooper","year":"2003","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0180","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10488-004-1670-3","article-title":"Race, managed care, and the quality of substance abuse treatment","volume":"32","author":"Daley","year":"2005","journal-title":"Adm. Policy Ment. Health"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1747-597X-3-17","article-title":"State policy influence on the early diffusion of buprenorphine in community treatment programs","volume":"3","author":"Ducharme","year":"2008","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1748-0361.2007.00118.x","article-title":"Drug use patterns and trends in rural communities","volume":"23","author":"Gfroerer","year":"2007","journal-title":"J. Rural Health"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0055","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s11606-008-0806-7","article-title":"Update in addiction medicine for the primary care clinician","volume":"23","author":"Gordon","year":"2008","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.drugalcdep.2007.03.010","article-title":"Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years","volume":"90","author":"Gordon","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00019053-200523010-00007","article-title":"A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting","volume":"23","author":"Harris","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2008.07.013","article-title":"Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients","volume":"99","author":"Jones","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jsat.2006.03.013","article-title":"Early buprenorphine adoption in substance abuse treatment centers: data from the public and private sectors","volume":"30","author":"Knudsen","year":"2006","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2006.08.013","article-title":"The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters","volume":"87","author":"Knudsen","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2005.12.005","article-title":"Characteristics of US substance abuse treatment facilities adopting buprenorphine in its initial stage of availability","volume":"83","author":"Koch","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.164.3.277","article-title":"Treating opioid dependence. Growing implications for primary care","volume":"164","author":"Krantz","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0095","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/00004583-200312000-00010","article-title":"Racial\/ethnic differences in the use of psychotropic medication in high-risk children and adolescents","volume":"42","author":"Leslie","year":"2003","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0100","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.jsat.2010.01.009","article-title":"From research to the real world: buprenorphine in the decade of the Clinical Trials Network","volume":"38","author":"Ling","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0105","first-page":"69","article-title":"Accuracy of diagnoses of schizophrenia in Medicaid claims","volume":"43","author":"Lurie","year":"1992","journal-title":"Hosp. Community Psych."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","article-title":"The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis","volume":"93","author":"Marsch","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1360-0443.2003.00335.x","article-title":"Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients","volume":"98","author":"Mattick","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0120","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0125","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0185","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/jclp.1105","article-title":"Predictors of deterioration among patients with substance-use disorders","volume":"57","author":"Moos","year":"2001","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0130","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective medical treatment of opiate addiction","volume":"280","author":"National Consensus Development Panel","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0135","unstructured":"National Institute of Drug Abuse, 2006. Principles of Effective Treatment for Criminal Justice Populations. Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0140","series-title":"Evidence-based Treatment Practices for Substance Use Disorders: Workshop Proceedings","author":"National Institute of Drug Abuse National Quality Forum","year":"2005"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9343(98)00194-6","article-title":"A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic","volume":"105","author":"O\u2019Connor","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2004.12.008","article-title":"The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?","volume":"79","author":"Sullivan","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0155","series-title":"Results from the 2009 National Survey on Drug Use and Health: Vol. 1. Summary of National Findings","author":"U.S. Department of Health Human Services","year":"2010"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0160","series-title":"Buprenorphine: Potential for Abuse. Intellegence Bulletin","author":"U.S. Department of Justice","year":"2004"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0165","doi-asserted-by":"crossref","unstructured":"Volkow, N.D., 2004. NIDA at 30: committed to scientific solutions for drug addiction problems. NIDA Notes, 19. http:\/\/www.drugabuse.gov\/NIDA_notes\/NNvol19N1\/DirRep. Accessed on January 15 2007.","DOI":"10.1037\/e541292006-002"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0190","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2105\/AJPH.92.1.92","article-title":"Adequacy of treatment for serious mental illness in the United States","volume":"92","author":"Wang","year":"2002","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0195","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1176\/appi.ajp.158.12.2027","article-title":"Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care","volume":"158","author":"Wells","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/SAR.S15151","article-title":"Gender and racial\/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network","author":"Wu","year":"2010","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archpsyc.58.1.55","article-title":"The quality of care for depressive and anxiety disorders in the United States","volume":"58","author":"Young","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2011.10.016_bib0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1176\/appi.ps.56.2.157","article-title":"Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths","volume":"56","author":"Zito","year":"2005","journal-title":"Psychiatr. Serv."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611004674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611004674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T18:50:54Z","timestamp":1560970254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871611004674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":41,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0376871611004674"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.10.016","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}